Last close · 16 Oct 2026
Rs 128.65 -0.96%
Valuation · at the close on 16 Oct 2026
BF Biosciences Limited (BFBIO) valuation
BFBIO has no positive earnings to compare its share price with, so P/E is not meaningful.
- P/E · today
- —
- FY2026
- 5-yr average— Sector median12.5×
- P/B · today
- —
- FY2026
- 5-yr average— Sector median3.14×
- EV/EBITDA · today
- —
- 5-yr average— Sector median6.7×
- Dividend yield · today
- —
- FY2026
- 5-yr average— Payers' median4.6%
Market value — at Rs 128.65. Sector medians use the latest close of 14 Pharmaceuticals companies; P/E and P/B only where earnings / book value are positive; the yield median covers dividend payers only. Not investment advice.
Valuation history
At each fiscal year-end price.
| Rs bn | FY2026 Jul 2025 – Jun 2026 | FY2025 Jul 2024 – Jun 2025 | FY2024 Jul 2023 – Jun 2024 | FY2023 Jul 2022 – Jun 2023 | FY2022 Jul 2021 – Jun 2022 | FY2021 Jul 2020 – Jun 2021 | FY2020 Jul 2019 – Jun 2020 |
|---|---|---|---|---|---|---|---|
| Market capitalisation | 12.6 | 14.9 | — | — | — | — | — |
| Enterprise value | 13.7 | 15.1 | — | — | — | — | — |
| Share price (period end) Rs | 142.88 | 168.70 | — | — | — | — | — |
| P/E (diluted) | — | 30.54× | — | — | — | — | — |
| Price to book | 2.38× | 3.20× | — | — | — | — | — |
| Price to sales | 1.33× | 2.34× | — | — | — | — | — |
| EV / EBITDA | 10.01× | 16.27× | — | — | — | — | — |
| EV / Sales | 1.44× | 2.59× | — | — | — | — | — |
| Dividend yield (gross) | 0.0% | 0.0% | — | — | — | — | — |
| Free cash flow yield | (5.6%) | (0.3%) | — | — | — | — | — |
| PEG ratio | 0.68× | 1.15× | — | — | — | — | — |
| P/E (diluted, normalised) | — | 30.69× | — | — | — | — | — |